AstraZeneca Wins Patent Dispute Over Crestor

NEW YORK - (AP) AstraZeneca Plc said Tuesday it won a patent challenge brought against its blockbuster cholesterol drug Crestor by generic drug developers. The U.S. District Court in Delaware ruled that a key patent on the company's third best-selling drug is valid and that challenger Apotex could...

AstraZeneca Pays $198M To Settle Seroquel Lawsuits

LONDON - (AP) AstraZeneca PLC says it has paid around $198 million to settle U.S. lawsuits over its antipsychotic drug Seroquel. Full version available to lexis.com subscriber .

Virginia Federal Jury Says Woman Didn't Prove Prempro Warnings Were Inadequate

ALEXANDRIA, Va. - (Mealey's) A Virginia federal jury on Dec. 3 found that a woman who claimed to have developed breast cancer from taking Wyeth's Prempro hormone replacement therapy drug did not prove that warnings provided to her doctor were inadequate ( Georgia Torkie-Tork v. Wyeth , No. 04...

Hunter Shkolnik Of Rheingold Valet Moves To Napoli Bern Ripka LLP

NEW YORK - After more than 15 years as a senior partner in the New York personal injury firm Rheingold, Valet, Rheingold, Shkolnik & McCartney LLP, Hunter Shkolnik has joined Napoli Bern Ripka LLP as a senior partner of the firm, which is now known as Napoli Bern Ripka Shkolnik LLP. Shkolnik has...

Federal Food, Drug, And Cosmetic Act Did Not Preclude Lanham Act Challenge That Asserted That Labeling, Marketing, And Advertising Was Misleading

On June 12, 2014, the United States Supreme Court decided the case of POM Wonderful LLC v. Coca-Cola Co., 189 L. Ed. 2d 141 (U.S. 2014) . POM Wonderful, LLC (POM) filed its initial action against Coca-Cola asserting that the labeling, marketing, and advertising for one of Coca-Cola’s juice blends...